A dense compendium of evidence is not enough to communicate product value to payers. Summarizing the best available evidence is important, but the dossier should also tell a story — accurately, succinctly and engagingly — about the value of your product. Our dedicated in-house team of specialist market access writers reviews the clinical, economic and humanistic evidence to develop compelling value stories, dossiers, payer communication decks and objection handlers.
Our value messages are often tested and validated with payers in key markets, and we are well-versed in the templates and formats for country-specific dossiers, including those for the U.S. (AMCP/WellPoint), Canada, the U.K. and various other European markets. For a successful journey through client review processes, we apply rigorous quality standards to all content development, with attention to primary referencing and appropriate interpretation of data drawn from the published literature.